Transcription of Farxiga Prescribing Information
{{id}} {{{paragraph}}}
Example: biology
Farxiga Prescribing Information
US-50977. HIGHLIGHTS OF Prescribing Information ------------------------- DOSAGE FORMS AND STRENGTHS ------------------------ These highlights do not include all the Information needed to use Farxiga Tablets: 5 mg and 10 mg (3). safely and effectively. See full Prescribing Information for Farxiga . ------------------------------ CONTRAINDICATIONS ------------------------------- Farxiga (dapagliflozin) tablets, for oral use Initial Approval: 2014 History of serious hypersensitivity reaction to Farxiga . (4). Patients on dialysis. (4). ----------------------------- RECENT MAJOR CHANGES ----------------------------- Indications and Usage (1) 04/2021 -------------------------- WARNINGS AND PRECAUTIONS -------------------------- Dosage and Administration ( , ) 04/2021 Ketoacidosis in Patients with Diabetes Mellitus: Assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis regardless of blood Dosage and Administration ( , ) removed 04/2021 glucose level.
acidosis and included nausea, vomiting, abdominal pain, generalized malaise, and shortness of breath. In some but not all cases, factors predisposing to ketoacidosis, such as insulin dose reduction, acute febrile illness, reduced caloric intake, surgery, pancreatic disorders suggesting insulin deficiency (e.g., type 1 diabetes, history of
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: